Biosimilar uptake in the U.S. could outpace adoption in the EU
10 May 2016
The U.S. may be arriving late to the biosimilar market, but it can make up the lost time through a speedier adoption of the follow-ons.
India in spotlight as Asian trade talks draw flak on generics access
10 May 2016
India's low-cost generic drug industry faces threats from a proposed 16-nation Asian trade bloc, according to civil society groups such as Médecins Sans Frontières.
Tobira Therapeutics Reports First Quarter 2016 Financial and Business Result
10 May 2016
Tobira Therapeutics, Inc. ( NASDAQ : TBRA), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel treatments for liver and inflammatory diseases, today reported business highlights and financial results for the three months ended March 31, 2016.
Chemotherapy drugs are able to fight inflammation
06 May 2016
Topoisomerase 1, known for its role in unwinding DNA during transcription and the target of chemotherapy drugs Camptosar (irinotecan, Pfizer Inc.) and Hycamtin (topotecan, GlaxoSmithKline plc.), plays a role in coordinating the innate immune response, and inhibiting it could be a therapeutic strategy in diseases characterized by excessive inflammation, scientists reported in the April 29, 2016, issue of Science.
US National Science and Technology Council Promotes Advanced Manufacturing
06 May 2016
Advanced biopharmaceutical manufacturing technologies, including continuous biopharmaceutical manufacturing, are among the "emerging priority" areas highlighted in an April 2016 report, “Advanced Manufacturing: A Snapshot of Priority Technology Areas Across the Federal Government,” by the Subcommittee for Advanced Manufacturing of the National Science and Technology Council.
NIH Study Identifies Better Parameter to Predict Flu Vaccine Effectiveness
06 May 2016
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a branch of the National Institutes of Health (NIH), have concluded that an antigen other than the one that is typically used for the creation of flu vaccines may be a more effective target for the prevention of infection.
Digital data connections rule for Gartner's new 'cool vendors' in life sciences
05 May 2016
This year's class of Gartner's "cool vendors" are small but mighty. They're not large, established corporations, but they're agile, with the ability to deliver insights and innovation quickly for pharma companies. The five for 2016 include sales and marketing ventures Aktana, InCrowd and Treato, along with more R&D-focused companies AICure and Infinote.
Biotech entrepreneur, Harvard prof Verdine adds WuXi startup player to CV
05 May 2016
Serial biotech entrepreneur and Harvard professor Greg Verdine can add another title to his lengthy resume: venture partner and biotech startup point man for WuXi Healthcare Ventures.
Better Together: The Next Wave of Cancer Immunotherapy
05 May 2016
Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the power of the immune system to target and fight disease. Today, this burgeoning field of immuno-oncology is revolutionizing how we perceive and treat cancer. We are witnessing the emergence of a new vision within this field – where rational combinations can benefit more patients faced with life-threatening disease.
Quintiles, IMS Health unveil surprise megamerger
05 May 2016
The world’s largest CRO, Quintiles, and healthcare consultancy IMS Health have unveiled a major megamerger deal which could create a company worth nearly $18 billion.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024